Browse this journal

Latest articles

‘Latest articles’ are articles accepted for publication in this journal but not yet published in a volume/issue. Articles are removed from the ‘Latest articles’ list when they are published in a volume/issue. Latest articles are citable using the author(s), year of online publication, article title, journal and article DOI.

Download Citation Download PDFs

Review Article

Review Article
Medical treatments for abdominal aortic aneurysm: an overview of clinical trials
Jinyi Chen, Lanting Hu & Zhenjie Liu
Accepted author version posted online: 08 Jul 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
New investigational drugs for Steroid-Refractory Acute Graft-versus-Host disease: a review of the literature
Na Hyun Kim, Mehdi Hamadani & Sameem Abedin
Accepted author version posted online: 08 Jul 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions
William C. Upshaw, John M. Richey, Gurjot Ravi, Adrian Chen, Shahab Ahmadzadeh, Sahar Shekoohi, Omar Viswanath & Alan D. Kaye
Published online: 08 Jul 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs
Marco Sebastiani, Andreina Manfredi, Stefania Croci, Paola Faverio, Giulia Cassone, Caterina Vacchi, Carlo Salvarani & Fabrizio Luppi
Published online: 05 Jul 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Trastuzumab-Deruxtecan in solid tumors with HER2 alterations: from early phase development to the first agnostic approval of an antibody-drug conjugate.
Crimini Edoardo & Curigliano Giuseppe
Accepted author version posted online: 05 Jul 2024
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development
Claudio Cruciani, Marile Gatto, Luca Iaccarino, Andrea Doria & Margherita Zen
Accepted author version posted online: 03 Jul 2024
  • 9 Views
  • 0 CrossRef citations
  • 0Altmetric

Editorial

Editorial
VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol
Amanda J. Hooper, Xuan L. Tang & John R. Burnett
Published online: 21 Jun 2024
  • 390 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs
Lorenza Magagnoli, Paola Ciceri & Mario Cozzolino
Published online: 19 Jun 2024
  • 55 Views
  • 0 CrossRef citations
  • 0Altmetric

Special Report

Report
Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development
Luca Iorio, Roberto Padoan, Milena Bond & Christian Dejaco
Published online: 16 Jun 2024
  • 90 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
Ling Yang, Yuan Fang, Yuan Luo, Meng Fu, Kai Shen & Zhu Luo
Published online: 03 Jun 2024
  • 38 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy
Ava Aghakhani, Parmida Sadat Pezeshki & Nima Rezaei
Published online: 30 May 2024
  • 83 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration
Shogo Hashimoto, Narihito Nagoshi, Masaya Nakamura & Hideyuki Okano
Published online: 29 May 2024
  • 35 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases
Nadia Martinez Naya, Jazmin Kelly, Austin Hogwood, Antonio Abbate & Stefano Toldo
Published online: 09 May 2024
  • 93 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies
Virginia Fuochi, Salvatore Furnari, Laura Trovato, Maddalena Calvo & Pio Maria Furneri
Published online: 09 May 2024
  • 31 Views
  • 0 CrossRef citations
  • 0Altmetric

Editorial

Editorial
Will new investigational drugs change the way we treat Charcot-Marie-Tooth disease?
Amedeo De Grado, Chiara Pisciotta, Paola Saveri & Davide Pareyson
Published online: 08 May 2024
  • 367 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Report
Investigational bispecific antibodies for the treatment of rheumatoid arthritis
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari & Alexandros A. Drosos
Published online: 08 May 2024
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric

Editorial

Editorial
Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease
P. Mihika S. Fernando, Amanda J. Hooper & John R. Burnett
Published online: 08 May 2024
  • 588 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
Gabrio Bassotti
Published online: 25 Apr 2024
  • 196 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days